MiniMed Group, Inc.
Moat Score — MiniMed Group, Inc.
Total Moat Score
9 / 30
| Moat Factor | Score | Analysis |
|---|---|---|
| Intangible Assets Patents, trademarks, brand strength, or regulatory licenses that protect a company's products or services from being freely copied by competitors. | 3 / 5 | MiniMed holds over 2,000 patents and applications and markets the only fully integrated pump-plus-CGM-plus-algorithm-plus-smart-pen system on the market, giving it real IP and platform differentiation, though newer entrants are closing the technology gap with their own cleared AID systems. |
| Cost Advantage A durable ability to produce goods or services more cheaply than competitors — through scale, unique access to cheap inputs, location, or process — that lets a company undercut rivals or out-earn them at the same price. | 1 / 5 | Over five million pumps produced since 2001 and a large installed base give MiniMed meaningful manufacturing scale, but widening net losses and a one-time $157M MiniMed Flex charge show the cost structure is not yet translating into a durable cost edge over Tandem or Insulet. |
| Pricing Power The ability to raise prices without losing meaningful business, because the product or service is differentiated, mission-critical, or has few good substitutes. | 1 / 5 | Reimbursement-driven DME and pharmacy channels limit outright pricing power, and the filing concedes competitive claims rest on indirect rather than head-to-head trial data, which constrains MiniMed's ability to command a premium over rival AID systems. |
| Network Effect The product or service becomes more valuable to every user as more people or organizations use it, making an established leader harder to displace. | 1 / 5 | CareLink software and the broader care-team/data ecosystem around 640,000+ 780G users creates mild clinician familiarity and data-network benefits, but the effect is modest compared to true multi-sided network businesses. |
| Switching Costs The money, time, or operational disruption a customer would face switching to a competitor, which locks in existing customers and supports renewals. | 2 / 5 | Patients and clinicians trained on a specific pump/CGM/algorithm combination face real friction switching systems, and MiniMed's large installed base and clinician familiarity reinforce this, though newer patients choose freely among AID systems at diagnosis. |
| Efficient Scale A market that can only profitably support a small number of players, so incumbents face limited threat from new entrants even without other defenses. | 1 / 5 | MiniMed is the largest player by installed base in automated insulin delivery, but the still-widening net losses and separation overhang from Medtronic indicate the business has not yet converted its scale into an efficient, defensible economic position. |